首页 > 最新文献

Indian Pacing and Electrophysiology Journal最新文献

英文 中文
Dofetilide in atrial fibrillation: A comprehensive review 多非利特在房颤中的应用综述。
Q3 Medicine Pub Date : 2025-11-01 Epub Date: 2025-11-28 DOI: 10.1016/j.ipej.2025.11.013
Diksha Mahendru , Harin D. Joshi , Peter Kowey
Atrial fibrillation is the most common sustained cardiac arrhythmia and is associated with significant morbidity, mortality, and healthcare burden worldwide. The management of AF remains complex, encompassing rate and rhythm control strategies, anticoagulation, and comorbidity optimization. Dofetilide, a class III antiarrhythmic agent, has emerged as an important therapeutic option for rhythm control due to its relatively selective blockade of the rapid component of the delayed rectifier potassium current (IKr). Unlike many other antiarrhythmics, it lacks significant negative inotropy, making it safe for use in patients with structural heart disease and left ventricular dysfunction. However, its use is limited by concerns regarding torsades de pointes, mandatory in-hospital initiation, and stringent monitoring requirements. This review provides a comprehensive analysis of dofetilide, including its pharmacology, clinical trial evidence, safety profile, guideline recommendations, role in special populations, real-world application in India, and future perspectives.
房颤是最常见的持续性心律失常,在世界范围内具有显著的发病率、死亡率和医疗负担。房颤的管理仍然很复杂,包括心率和节律控制策略、抗凝和合并症优化。多非利特是一种III类抗心律失常药物,由于其相对选择性地阻断延迟整流钾电流(IKr)的快速组分,已成为心律控制的重要治疗选择。与许多其他抗心律失常药不同,它没有明显的负性肌力,因此可以安全用于结构性心脏病和左心室功能障碍患者。然而,它的使用受到一些问题的限制,如:关节扭转、强制在医院内启动以及严格的监测要求。本综述提供了对多非利特的全面分析,包括其药理学、临床试验证据、安全性、指南建议、在特殊人群中的作用、在印度的实际应用以及未来前景。
{"title":"Dofetilide in atrial fibrillation: A comprehensive review","authors":"Diksha Mahendru ,&nbsp;Harin D. Joshi ,&nbsp;Peter Kowey","doi":"10.1016/j.ipej.2025.11.013","DOIUrl":"10.1016/j.ipej.2025.11.013","url":null,"abstract":"<div><div>Atrial fibrillation is the most common sustained cardiac arrhythmia and is associated with significant morbidity, mortality, and healthcare burden worldwide. The management of AF remains complex, encompassing rate and rhythm control strategies, anticoagulation, and comorbidity optimization. Dofetilide, a class III antiarrhythmic agent, has emerged as an important therapeutic option for rhythm control due to its relatively selective blockade of the rapid component of the delayed rectifier potassium current (IKr). Unlike many other antiarrhythmics, it lacks significant negative inotropy, making it safe for use in patients with structural heart disease and left ventricular dysfunction. However, its use is limited by concerns regarding torsades de pointes, mandatory in-hospital initiation, and stringent monitoring requirements. This review provides a comprehensive analysis of dofetilide, including its pharmacology, clinical trial evidence, safety profile, guideline recommendations, role in special populations, real-world application in India, and future perspectives.</div></div>","PeriodicalId":35900,"journal":{"name":"Indian Pacing and Electrophysiology Journal","volume":"25 6","pages":"Pages 451-457"},"PeriodicalIF":0.0,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145649599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spontaneous variability in intracardiac intervals during supraventricular tachycardia: Electrophysiologic mechanisms 室上性心动过速时心内间隔的自发变异性:电生理机制。
Q3 Medicine Pub Date : 2025-11-01 Epub Date: 2025-11-18 DOI: 10.1016/j.ipej.2025.11.004
Devendra Singh Bisht, Kamal Kishor

Background

The exact nature of the circuit and the existence of the upper and lower common pathways in Atrioventricular nodal re-entrant tachycardia (AVNRT) are not well defined.

Methods and results

This report describes a case of re-entrant supraventricular tachycardia in which electrophysiologic manoeuvres confirmed an atypical AVNRT. During the tachycardia there was spontaneous variability in intracardiac intervals, and possible mechanisms are discussed. The tachycardia resolved after slow-pathway ablation.

Conclusion

Atypical AVNRT can cause spontaneous intracardiac interval variability that complicates diagnosis but is effectively treated with targeted slow-pathway ablation.
背景:房室结型再入性心动过速(AVNRT)的电路的确切性质和上下共同通路的存在尚不明确。方法和结果:本报告描述了一例再入性室上性心动过速,其中电生理操作证实了非典型AVNRT。在心动过速期间,心内间隔有自发变异性,并讨论了可能的机制。慢径消融后,心动过速消退。结论:非典型AVNRT可引起自发性心内间隔变异性,使诊断复杂化,但可通过靶向慢路消融有效治疗。
{"title":"Spontaneous variability in intracardiac intervals during supraventricular tachycardia: Electrophysiologic mechanisms","authors":"Devendra Singh Bisht,&nbsp;Kamal Kishor","doi":"10.1016/j.ipej.2025.11.004","DOIUrl":"10.1016/j.ipej.2025.11.004","url":null,"abstract":"<div><h3>Background</h3><div>The exact nature of the circuit and the existence of the upper and lower common pathways in Atrioventricular nodal re-entrant tachycardia (AVNRT) are not well defined.</div></div><div><h3>Methods and results</h3><div>This report describes a case of re-entrant supraventricular tachycardia in which electrophysiologic manoeuvres confirmed an atypical AVNRT. During the tachycardia there was spontaneous variability in intracardiac intervals, and possible mechanisms are discussed. The tachycardia resolved after slow-pathway ablation.</div></div><div><h3>Conclusion</h3><div>Atypical AVNRT can cause spontaneous intracardiac interval variability that complicates diagnosis but is effectively treated with targeted slow-pathway ablation.</div></div>","PeriodicalId":35900,"journal":{"name":"Indian Pacing and Electrophysiology Journal","volume":"25 6","pages":"Pages 414-416"},"PeriodicalIF":0.0,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145565701","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inappropriate automated implantable cardioverted defibrillator therapy despite dual chamber device and evident atrial arrhythmia- what is the mechanism? 尽管有双室装置和明显的心房心律失常,但不适当的自动植入式心脏除颤器治疗-机制是什么?
Q3 Medicine Pub Date : 2025-11-01 Epub Date: 2025-11-18 DOI: 10.1016/j.ipej.2025.11.003
Amira Shaik , Sanjeev S. Mukherjee , Saroj Kumar Choudhury , Debabrata Bera
{"title":"Inappropriate automated implantable cardioverted defibrillator therapy despite dual chamber device and evident atrial arrhythmia- what is the mechanism?","authors":"Amira Shaik ,&nbsp;Sanjeev S. Mukherjee ,&nbsp;Saroj Kumar Choudhury ,&nbsp;Debabrata Bera","doi":"10.1016/j.ipej.2025.11.003","DOIUrl":"10.1016/j.ipej.2025.11.003","url":null,"abstract":"","PeriodicalId":35900,"journal":{"name":"Indian Pacing and Electrophysiology Journal","volume":"25 6","pages":"Pages 425-428"},"PeriodicalIF":0.0,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145565733","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
One-Year Outcomes of Device-Detected Atrial High-Rate Episodes in the Indian Population: A Prospective Observational Study 印度人群中器械检测心房高发生率发作的一年结果:一项前瞻性观察研究
Q3 Medicine Pub Date : 2025-11-01 Epub Date: 2025-12-22 DOI: 10.1016/j.ipej.2025.12.012
S. Shanmugam , S.P. Abhilash , J. Vijay , S. Sreedharan , N. Namboodiri
{"title":"One-Year Outcomes of Device-Detected Atrial High-Rate Episodes in the Indian Population: A Prospective Observational Study","authors":"S. Shanmugam ,&nbsp;S.P. Abhilash ,&nbsp;J. Vijay ,&nbsp;S. Sreedharan ,&nbsp;N. Namboodiri","doi":"10.1016/j.ipej.2025.12.012","DOIUrl":"10.1016/j.ipej.2025.12.012","url":null,"abstract":"","PeriodicalId":35900,"journal":{"name":"Indian Pacing and Electrophysiology Journal","volume":"25 6","pages":"Page 473"},"PeriodicalIF":0.0,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145801877","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Left atrial appendage edema and spontaneous echo contrast following pulsed field ablation for pulmonary vein isolation: A case report. 肺静脉隔离脉冲场消融后左心耳水肿及自发回声对比1例报告。
Q3 Medicine Pub Date : 2025-10-16 DOI: 10.1016/j.ipej.2025.10.006
Jefri Lim, Beny Hartono, Evan J Gunawan, Dian L Munawar, Firman Tedjasukmana, Muhammad Munawar

Pulsed Field Ablation (PFA) is a novel non-thermal ablation technique with several advantages and fewer complications. A 70-year-old male with persistent atrial fibrillation, heart failure with preserved ejection fraction, and prior ischemic stroke who underwent pulmonary vein isolation using PFA with planned left atrial appendage closure (LAAC). Post-ablation transesophageal echocardiography revealed significant dense spontaneous echo contrast in the left atrial appendage (LAA) and left atrial ridge edema, leading to LAAC postponement and anticoagulation initiation. While PFA has advantages over conventional ablation, its impact on LAA structures requires further study, especially when considering concomitant with LAAC.

脉冲场消融(PFA)是一种新型的非热消融技术,具有诸多优点和较少的并发症。一位70岁男性患者,患有持续性心房颤动,心力衰竭并保留射血分数,既往缺血性中风,使用PFA进行肺静脉隔离并计划左心房附件关闭(LAAC)。消融后经食管超声心动图显示左心房附件(LAA)明显致密自发回声对比,左心房脊水肿,导致LAAC延迟和抗凝起始。虽然PFA比传统消融有优势,但其对LAA结构的影响还需要进一步研究,特别是当考虑与LAAC合用时。
{"title":"Left atrial appendage edema and spontaneous echo contrast following pulsed field ablation for pulmonary vein isolation: A case report.","authors":"Jefri Lim, Beny Hartono, Evan J Gunawan, Dian L Munawar, Firman Tedjasukmana, Muhammad Munawar","doi":"10.1016/j.ipej.2025.10.006","DOIUrl":"10.1016/j.ipej.2025.10.006","url":null,"abstract":"<p><p>Pulsed Field Ablation (PFA) is a novel non-thermal ablation technique with several advantages and fewer complications. A 70-year-old male with persistent atrial fibrillation, heart failure with preserved ejection fraction, and prior ischemic stroke who underwent pulmonary vein isolation using PFA with planned left atrial appendage closure (LAAC). Post-ablation transesophageal echocardiography revealed significant dense spontaneous echo contrast in the left atrial appendage (LAA) and left atrial ridge edema, leading to LAAC postponement and anticoagulation initiation. While PFA has advantages over conventional ablation, its impact on LAA structures requires further study, especially when considering concomitant with LAAC.</p>","PeriodicalId":35900,"journal":{"name":"Indian Pacing and Electrophysiology Journal","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145318734","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial intelligence in ventricular arrhythmias and sudden cardiac death: A guide for clinicians. 人工智能在室性心律失常和心源性猝死中的应用:临床医生指南。
Q3 Medicine Pub Date : 2025-09-27 DOI: 10.1016/j.ipej.2025.09.005
Ibrahim Antoun, Xin Li, Ahmed Abdelrazik, Mahmoud Eldesouky, Kaung Myat Thu, Mokhtar Ibrahim, Harshil Dhutia, Riyaz Somani, G André Ng

Sudden cardiac death (SCD) from ventricular arrhythmias (VAs) remains a leading cause of mortality worldwide. Traditional risk stratification, primarily based on left ventricular ejection fraction (LVEF) and other coarse metrics, often fails to identify a large subset of patients at risk and frequently leads to unnecessary device implantations. Advances in artificial intelligence (AI) offer new strategies to improve both long-term SCD risk prediction and near-term VAs forecasting. In this review, we discuss how AI algorithms applied to the 12-lead electrocardiogram (ECG) can identify subtle risk markers in conditions such as hypertrophic cardiomyopathy (HCM), arrhythmogenic right ventricular cardiomyopathy (ARVC), and coronary artery disease (CAD), often outperforming conventional risk models. We also explore the integration of AI with cardiac imaging, such as scar quantification on cardiac magnetic resonance (CMR) and fibrosis mapping, to enhance the identification of the arrhythmogenic substrate. Furthermore, we investigate the application of data from implantable cardioverter-defibrillators (ICDs) and wearable devices to predict ventricular tachycardia (VT) or ventricular fibrillation (VF) events before they occur, thereby advancing care toward real-time prevention. Amid these innovations, we address the medicolegal and ethical implications of AI-driven automated alerts in arrhythmia care, highlighting when clinicians can trust AI predictions. Future directions include multimodal AI fusion to personalize SCD risk assessment, as well as AI-guided VT ablation planning through imaging-based digital heart models. This review provides a comprehensive overview for general medical readers, focusing on peer-reviewed advances globally in the emerging intersection of AI, VAs, and SCD prevention.

室性心律失常(VAs)引起的心源性猝死(SCD)仍然是世界范围内死亡的主要原因。传统的风险分层,主要基于左室射血分数(LVEF)和其他粗略的指标,往往不能识别出大量的高危患者,并经常导致不必要的装置植入。人工智能(AI)的进步为改善长期SCD风险预测和近期VAs预测提供了新的策略。在这篇综述中,我们讨论了应用于12导联心电图(ECG)的人工智能算法如何识别肥厚性心肌病(HCM)、心律失常性右室心肌病(ARVC)和冠状动脉疾病(CAD)等疾病的微妙风险标记,通常优于传统的风险模型。我们还探索了人工智能与心脏成像的整合,如心脏磁共振(CMR)疤痕量化和纤维化制图,以增强对心律失常底物的识别。此外,我们研究了植入式心律转复除颤器(icd)和可穿戴设备的数据在室性心动过速(VT)或心室颤动(VF)事件发生之前的应用,从而推动了实时预防的护理。在这些创新中,我们解决了人工智能驱动的心律失常护理自动警报的医学和伦理影响,强调了临床医生何时可以信任人工智能预测。未来的发展方向包括多模式人工智能融合,以个性化SCD风险评估,以及通过基于成像的数字心脏模型,人工智能引导VT消融计划。这篇综述为普通医学读者提供了一个全面的概述,重点是在AI、VAs和SCD预防的新兴交叉领域,全球同行评审的进展。
{"title":"Artificial intelligence in ventricular arrhythmias and sudden cardiac death: A guide for clinicians.","authors":"Ibrahim Antoun, Xin Li, Ahmed Abdelrazik, Mahmoud Eldesouky, Kaung Myat Thu, Mokhtar Ibrahim, Harshil Dhutia, Riyaz Somani, G André Ng","doi":"10.1016/j.ipej.2025.09.005","DOIUrl":"10.1016/j.ipej.2025.09.005","url":null,"abstract":"<p><p>Sudden cardiac death (SCD) from ventricular arrhythmias (VAs) remains a leading cause of mortality worldwide. Traditional risk stratification, primarily based on left ventricular ejection fraction (LVEF) and other coarse metrics, often fails to identify a large subset of patients at risk and frequently leads to unnecessary device implantations. Advances in artificial intelligence (AI) offer new strategies to improve both long-term SCD risk prediction and near-term VAs forecasting. In this review, we discuss how AI algorithms applied to the 12-lead electrocardiogram (ECG) can identify subtle risk markers in conditions such as hypertrophic cardiomyopathy (HCM), arrhythmogenic right ventricular cardiomyopathy (ARVC), and coronary artery disease (CAD), often outperforming conventional risk models. We also explore the integration of AI with cardiac imaging, such as scar quantification on cardiac magnetic resonance (CMR) and fibrosis mapping, to enhance the identification of the arrhythmogenic substrate. Furthermore, we investigate the application of data from implantable cardioverter-defibrillators (ICDs) and wearable devices to predict ventricular tachycardia (VT) or ventricular fibrillation (VF) events before they occur, thereby advancing care toward real-time prevention. Amid these innovations, we address the medicolegal and ethical implications of AI-driven automated alerts in arrhythmia care, highlighting when clinicians can trust AI predictions. Future directions include multimodal AI fusion to personalize SCD risk assessment, as well as AI-guided VT ablation planning through imaging-based digital heart models. This review provides a comprehensive overview for general medical readers, focusing on peer-reviewed advances globally in the emerging intersection of AI, VAs, and SCD prevention.</p>","PeriodicalId":35900,"journal":{"name":"Indian Pacing and Electrophysiology Journal","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145193295","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A high-resolution mirage: Navigating atrial flutter circuits in the era of automated mapping 高分辨率海市蜃楼:在自动绘图时代导航心房扑动电路。
Q3 Medicine Pub Date : 2025-09-01 Epub Date: 2025-08-12 DOI: 10.1016/j.ipej.2025.08.003
Shivaraj Patil MBBS, Nayani Makkar MBBS, Abhishek J. Deshmukh MBBS
{"title":"A high-resolution mirage: Navigating atrial flutter circuits in the era of automated mapping","authors":"Shivaraj Patil MBBS,&nbsp;Nayani Makkar MBBS,&nbsp;Abhishek J. Deshmukh MBBS","doi":"10.1016/j.ipej.2025.08.003","DOIUrl":"10.1016/j.ipej.2025.08.003","url":null,"abstract":"","PeriodicalId":35900,"journal":{"name":"Indian Pacing and Electrophysiology Journal","volume":"25 5","pages":"Pages 341-342"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144856592","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Jumps and concealed conduction: Interactions between a manifest anteroseptal accessory pathway and the fast and slow pathways of the atrioventricular node 跳跃和隐蔽传导:明显的前间隔副通路与房室结快慢通路之间的相互作用。
Q3 Medicine Pub Date : 2025-09-01 Epub Date: 2025-10-17 DOI: 10.1016/j.ipej.2025.10.001
Behzad B. Pavri
{"title":"Jumps and concealed conduction: Interactions between a manifest anteroseptal accessory pathway and the fast and slow pathways of the atrioventricular node","authors":"Behzad B. Pavri","doi":"10.1016/j.ipej.2025.10.001","DOIUrl":"10.1016/j.ipej.2025.10.001","url":null,"abstract":"","PeriodicalId":35900,"journal":{"name":"Indian Pacing and Electrophysiology Journal","volume":"25 5","pages":"Pages 374-378"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145330253","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Signature ECG 3: A case of long QT 3 syndrome (LQT3) 特征心电图3:长QT3综合征(LQT3) 1例。
Q3 Medicine Pub Date : 2025-09-01 Epub Date: 2025-07-26 DOI: 10.1016/j.ipej.2025.07.015
Anand Manickavasagam , Priya Chockalingam , Arthur AM. Wilde
{"title":"Signature ECG 3: A case of long QT 3 syndrome (LQT3)","authors":"Anand Manickavasagam ,&nbsp;Priya Chockalingam ,&nbsp;Arthur AM. Wilde","doi":"10.1016/j.ipej.2025.07.015","DOIUrl":"10.1016/j.ipej.2025.07.015","url":null,"abstract":"","PeriodicalId":35900,"journal":{"name":"Indian Pacing and Electrophysiology Journal","volume":"25 5","pages":"Pages 357-358"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144733605","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Electrical storm of short coupled ventricular fibrillation- management by neuromodulation and trigger ablation 短联性心室颤动的电风暴-神经调节和触发消融术的治疗。
Q3 Medicine Pub Date : 2025-09-01 Epub Date: 2025-07-11 DOI: 10.1016/j.ipej.2025.07.001
Vivek Narasimha V , Nagalaxmi Patnala , Anoop Agrawal , B. Hygriv Rao
We present the case of a young lady with prior implanted ICD presenting with Electrical storm (ES) of short coupled ventricular fibrillation (SCVF). The clinical emergency was managed by a novel technique of fluoroscopy guided stellate ganglion ablation followed by 3D mapping guided ectopy ablation. This is to the best of our knowledge the first report of such a malignant phenotype treated by the combination and sequence of these treatment modalities.
我们提出的情况下,一个年轻的女士先前植入ICD提出电风暴(ES)的短偶联心室颤动(SCVF)。临床急诊是通过一种新的技术,引导星状神经节消融后,三维绘图引导触发消融处理。据我们所知,这是这些治疗方式的组合和顺序治疗这种恶性表型的第一份报告。
{"title":"Electrical storm of short coupled ventricular fibrillation- management by neuromodulation and trigger ablation","authors":"Vivek Narasimha V ,&nbsp;Nagalaxmi Patnala ,&nbsp;Anoop Agrawal ,&nbsp;B. Hygriv Rao","doi":"10.1016/j.ipej.2025.07.001","DOIUrl":"10.1016/j.ipej.2025.07.001","url":null,"abstract":"<div><div>We present the case of a young lady with prior implanted ICD presenting with Electrical storm (ES) of short coupled ventricular fibrillation (SCVF). The clinical emergency was managed by a novel technique of fluoroscopy guided stellate ganglion ablation followed by 3D mapping guided ectopy ablation. This is to the best of our knowledge the first report of such a malignant phenotype treated by the combination and sequence of these treatment modalities.</div></div>","PeriodicalId":35900,"journal":{"name":"Indian Pacing and Electrophysiology Journal","volume":"25 5","pages":"Pages 323-327"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144627335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Indian Pacing and Electrophysiology Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1